Enabling your biologics discovery and development
We share your mission: To speed your breakthrough innovations to market and ultimately to the people who can benefit from them most. From immunotherapies to cancer vaccines, the range of new therapies emerging from the scientific pursuit of improved health outcomes is astounding. But there is still a vast amount of work to do.
We understand the need for a rapid, end-to-end drug development and how to navigate and streamline the drug development process. From biologics discovery to commercialization, our innovative and flexible tools, scalable solutions, and custom services help accelerate your success.
Our solutions for the therapeutic, vaccine and
Explore our expanse of highly sensitive products and scalable solutions to help you quickly and accurately identify antigens, and render high quality and high yields of pathogen components.
High-quality RUO products for early T cell–based immunotherapy development and GMP-manufactured CTS products to support your transition to clinical and commercial applications.
End-to-end solutions to help you rapidly discover and validate new therapeutic targets, simplify compound hit characterization and confidently validate compound safety.
With higher incidences of chronic illnesses around the world, the need for effective therapies is greater than ever. From stem cell therapies designed to aid the regeneration of cells and tissue, to gene therapies that attempt to address disease by transforming a patient’s DNA, the potential of novel therapeutics to help treat diseases offers new hope for patients and the promise of personalized care for everyone.
Companies developing biologic drugs face a volatile and competitive market where best-in-class tools and support can mean the difference between failure and success. Check out some of our resources for support and insights from our experts.